soquelitinib — Initial data
Late 2026
Results from cohort 1 (100 mg twice per day, 200 mg once per day and placebo) are anticipated late this year.Source filing
CRVS biotech catalysts & pipeline
CORVUS PHARMACEUTICALS INC · Data as of 2026-10-25
Upcoming catalysts
soquelitinib — Interim data
early 2027
An interim futility analysis is planned after a defined number of progression events occurs.Source filing